Pacira Pharmaceuticals Inc. said Thursday it has named Scott Braunstein as chief operation officer and Richard Scranton as chief scientific officer. Scranton will head research, while leading communications and market access for Exparel, the company’s non-opioid treatment for managing post-surgical pain. Shares were not yet active premarket, but have gained 34% in 2017, while the S&P 500 has gained 17%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Latest posts by Market Watch (see all)
- Chinese content-aggregation app Qutoutiao files for IPO - August 17, 2018
- Avista Healthcare shares rise on deal to acquire Organogenesis - August 17, 2018
- Personal Finance Daily: What you should know about recording your coworkers and an important tax change - August 17, 2018